Cytochrome c Degradation: A Mechanism to Restrict Apoptosis in Postmitotic Cells
Cytochrome c Degradation: A Mechanism to Restrict Apoptosis in Postmitotic Cells
批准号:
8534158
负责人:
Mohanish P Deshmukh
金额:
$34.55万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-01 至 2014-08-31
关键词:
AffectApoptosisApoptoticBindingBinding ProteinsCardiacCardiac MyocytesCaspaseCell DeathCell SurvivalCellsCessation of lifeCytosolDegenerative DisorderEmployee StrikesEnsureEventFailureFibroblastsGoalsHeat-Shock Proteins 70LaboratoriesLifeMammalian CellMediatingMitochondriaMitoticMolecularMuscle FibersMuscular DystrophiesNeurodegenerative DisordersNeuronsOrganismPathologyPathway interactionsPhysiologicalPlayProteinsRegulationReportingRoleSafetyTestingUbiquitinUbiquitinationapoptotic protease-activating factor 1cancer cellclinically significantcytochrome chuman BIRC4 proteininhibitor-of-apoptosis proteinmulticatalytic endopeptidase complexnovelpreventpublic health relevanceregenerativeubiquitin-protein ligase
中文摘要
描述(申请人提供):严格调控细胞凋亡的能力对神经元、心肌细胞和肌管等有丝分裂后细胞特别重要,因为这些细胞的再生潜力有限,并在生物体的整个生命周期中保持。未能限制细胞凋亡会导致细胞死亡的易感性增加,这在许多退行性疾病中都可以看到。因此,了解有丝分裂后细胞的存活机制具有重要的生理和病理意义。细胞色素c(Cytc)的线粒体释放是细胞凋亡过程中触发caspase激活的重要事件。在这里,我们已经确定了一种新的机制来调控细胞色素c介导的由神经元和其他有丝分裂后细胞参与的凋亡,其中胞浆细胞色素c本身是蛋白酶体降解的靶标。重要的是,虽然我们没有观察到原代有丝分裂细胞如成纤维细胞中细胞色素c的降解,但我们发现线粒体释放的细胞色素c在某些癌细胞中也被降解。由于逃避凋亡是有丝分裂后细胞和癌细胞的重要特征,靶向胞浆Cytc的降解可能是这些细胞共同使用的生存机制。在这项提案中,我们的目标是确定胞质Cytc被作为降解靶点的分子机制。在目标1中,我们将定义决定细胞是否针对胞浆Cytc进行降解的因素,包括检查细胞中低水平的APAF-1是否是Cytc降解的关键决定因素。在目标2中,我们将研究细胞色素c泛素化,并确定针对泛素化的细胞色素c的特定残基。我们的假设是泛素化的Cytc不能与APAF-1结合。我们将测试这一点,并检查阻止细胞色素c降解的条件是否会增加有丝分裂后细胞对凋亡的脆弱性。我们在目标3中的重点是确定以Cyt c为降解目标的E3泛素连接酶。我们的初步结果表明,Cyt c与胞浆中的Hsp70和E3连接酶芯片(羧基热休克蛋白70相互作用蛋白)结合。因此,我们将测试在有丝分裂后细胞和癌细胞中,胞浆Cyt c的泛素化和降解是否由CHIP介导。
与公共卫生相关:我们的计划是研究哺乳动物细胞中细胞死亡途径是如何调节的。我们发现了一种新的机制,这种机制由神经元、心肌细胞和肌管等有丝分裂后细胞参与,高度限制细胞死亡,并可能确保它们的长期生存。了解有丝分裂后细胞的存活机制具有巨大的临床意义,因为这些细胞的死亡增加是许多神经退行性疾病、心脏病理和肌肉营养不良的重要病理基础。
英文摘要
DESCRIPTION (provided by applicant): The ability to strictly regulate apoptosis is particularly important for postmitotic cells such as neurons, cardiomyocytes and myotubes because these cells have limited regenerative potential and are maintained for the lifetime of the organism. Failure to restrict apoptosis can result in increased vulnerability to cell death, as seen in many degenerative diseases. Therefore, an understanding of survival mechanisms in postmitotic cells is of physiological and pathological importance. The mitochondrial release of cytochrome c (cyt c) is a crucial event that triggers caspase activation during apoptosis. Here, we have identified a novel mechanism for regulating cyt c-mediated apoptosis engaged by neurons and other postmitotic cells, where cytosolic cyt c itself is targeted for proteasomal degradation. Importantly, while we do not observe cyt c degradation in primary mitotic cells such as fibroblasts, we find mitochondrial-released cyt c to be also degraded in certain cancer cells. As evasion of apoptosis is an important feature of both postmitotic and cancer cells, targeting cytosolic cyt c for degradation could be a shared mechanism used by these cells for survival. In this proposal, our goals are to identify the molecular mechanisms by which cytosolic cyt c is targeted for degradation. In Aim 1, we will define the factors which determine whether or not a cell will target cytosolic cyt c for degradation, including examining whether low levels of Apaf-1 in cells is a key determinant for cyt c degradation. In Aim 2, we will examine cyt c ubiquitination and identify the specific residues of cyt c that are targeted for ubiquitination. Our hypothesis is that ubiquitinated cyt c is not able to bind Apaf-1. We will test this, and examine whether conditions that block cyt c degradation increase the vulnerability of postmitotic cells to apoptosis. Our focus in Aim 3 is to identify the E3 ubiquitin ligase that targets cyt c for degradation. Our preliminary results suggest that cyt c binds to Hsp70 and the E3 Ligase CHIP (Carboxyl Heat shock protein 70-Interacting Protein) in the cytosol. Therefore, we will test whether the ubiquitination and degradation of cytosolic cyt c is mediated by CHIP in postmitotic and cancer cells.
PUBLIC HEALTH RELEVANCE: Our plans here are to investigate how the cell death pathway is regulated in mammalian cells. We have discovered a novel mechanism engaged by postmitotic cells such as neurons, cardiomyocytes and myotubes that highly restricts cell death and likely ensures their long term survival. Understanding the survival mechanisms used by postmitotic cells has enormous clinical significance because increased death of these cells is central to the pathology of many neurodegenerative diseases, cardiac pathologies and muscular dystrophies.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.molcel.2012.04.002
发表时间:
2012-06-08
期刊:
MOLECULAR CELL
影响因子:
16
作者:
[Dumitru, Raluca, Gama, Vivian, Fagan, B. Matthew, Bower, Jacquelyn J., Swahari, Vijay, Pevny, Larysa H., Deshmukh, Mohanish]
通讯作者:
Deshmukh, Mohanish
Cerebellar granule neuron progenitors are the source of Hk2 in the postnatal cerebellum.
小脑颗粒神经元祖细胞是出生后小脑中 Hk2 的来源。
DOI:
10.1186/2049-3002-1-15
发表时间:
2013-06-11
期刊:
Cancer & metabolism
影响因子:
5.9
作者:
[Gershon TR, Crowther AJ, Liu H, Miller CR, Deshmukh M]
通讯作者:
Deshmukh M
DOI:
10.1038/onc.2012.248
发表时间:
2013-05-02
期刊:
ONCOGENE
影响因子:
8
作者:
[Garcia, I., Crowther, A. J., Gama, V., Miller, C. Ryan, Deshmukh, M., Gershon, T. R.]
通讯作者:
Gershon, T. R.
miR-29: A brain homeostasis molecule for Alzheimer’s disease prevention
-
批准号:10667151
-
项目类别:
-
资助金额:$62.28万
-
财政年份:2023
-
负责人:Mohanish P Deshmukh
-
依托单位:
Unexpected Function of Inflammasomes in Axon Pruning: Focus on NLRP1
-
批准号:10156766
-
项目类别:
-
资助金额:$163.79万
-
财政年份:2021
-
负责人:Mohanish P Deshmukh
-
依托单位:
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
-
批准号:10596657
-
项目类别:
-
资助金额:$38.29万
-
财政年份:2021
-
负责人:Mohanish P Deshmukh
-
依托单位:
Exploring Apoptosome-Independent Mechanisms for Casp9 activation in Axon Pruning
-
批准号:10288453
-
项目类别:
-
资助金额:$42.76万
-
财政年份:2021
-
负责人:Mohanish P Deshmukh
-
依托单位:
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
-
批准号:10417219
-
项目类别:
-
资助金额:$38.28万
-
财政年份:2021
-
负责人:Mohanish P Deshmukh
-
依托单位:
Essential Function of miR-29 in the Mature Brain
-
批准号:9904306
-
项目类别:
-
资助金额:$52.56万
-
财政年份:2017
-
负责人:Mohanish P Deshmukh
-
依托单位:
Establishing Apoptotic Thresholds: Insights from Neurons and Stem Cells to Cancer
-
批准号:9281085
-
项目类别:
-
资助金额:$52.36万
-
财政年份:2016
-
负责人:Mohanish P Deshmukh
-
依托单位:
Establishing Apoptotic Thresholds: Insights from Neurons and Stem Cells to Cancer
-
批准号:9351806
-
项目类别:
-
资助金额:$3.66万
-
财政年份:2016
-
负责人:Mohanish P Deshmukh
-
依托单位:
Establishing Apoptotic Thresholds: Insights from Neurons and Stem Cells to Cancer
-
批准号:9079061
-
项目类别:
-
资助金额:$17.97万
-
财政年份:2016
-
负责人:Mohanish P Deshmukh
-
依托单位:
Focus on Dicer inhibition as a novel treatment for brain tumors
-
批准号:9149075
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2015
-
负责人:Mohanish P Deshmukh
-
依托单位:
Focus on Dicer inhibition as a novel treatment for brain tumors
-
批准号:9056040
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2015
-
负责人:Mohanish P Deshmukh
-
依托单位:
Axon Degeneration and Apoptosis: Molecular Intersection of Two Distinct Pathways
-
批准号:8870563
-
项目类别:
-
资助金额:$37.7万
-
财政年份:2014
-
负责人:Mohanish P Deshmukh
-
依托单位:
Mechanism by which Human ES Cells Prime Bax at the Golgi for Rapid Apoptosis
-
批准号:8826776
-
项目类别:
-
资助金额:$41.61万
-
财政年份:2013
-
负责人:Mohanish P Deshmukh
-
依托单位:
Mechanism by which Human ES Cells Prime Bax at the Golgi for Rapid Apoptosis
-
批准号:8635379
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2013
-
负责人:Mohanish P Deshmukh
-
依托单位:
Mechanism by which Human ES Cells Prime Bax at the Golgi for Rapid Apoptosis
-
批准号:8473309
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2013
-
负责人:Mohanish P Deshmukh
-
依托单位:
Mechanism by which Human ES Cells Prime Bax at the Golgi for Rapid Apoptosis
-
批准号:8898490
-
项目类别:
-
资助金额:$10.64万
-
财政年份:2013
-
负责人:Mohanish P Deshmukh
-
依托单位:
Assay Development for High Throughput Screening
-
批准号:7620190
-
项目类别:
-
资助金额:$8.5万
-
财政年份:2008
-
负责人:Mohanish P Deshmukh
-
依托单位:
Apoptosis in Postmitotic Cells: Increased Regulation and Novel Checkpoints
-
批准号:7135331
-
项目类别:
-
资助金额:$27.58万
-
财政年份:2006
-
负责人:Mohanish P Deshmukh
-
依托单位:
Chemical Probes for Uncovering Differential Regulators o
-
批准号:7169699
-
项目类别:
-
资助金额:$7.3万
-
财政年份:2006
-
负责人:Mohanish P Deshmukh
-
依托单位:
Apoptosis in Postmitotic Cells: Increased Regulation and Novel Checkpoints
-
批准号:7671275
-
项目类别:
-
资助金额:$40.1万
-
财政年份:2006
-
负责人:Mohanish P Deshmukh
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: